{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T10:24:12Z","timestamp":1790850252102,"version":"4.1.0"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s40266-022-00998-z","type":"journal-article","created":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T12:04:20Z","timestamp":1675685060000},"page":"91-103","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Status Epilepticus in Older Adults: Diagnostic and Treatment Considerations"],"prefix":"10.1007","volume":"40","author":[{"given":"Gamaleldin M.","family":"Osman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8072-564X","authenticated-orcid":false,"given":"Sara E.","family":"Hocker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,6]]},"reference":[{"issue":"4","key":"998_CR1","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/00004691-199512040-00003","volume":"12","author":"RJ DeLorenzo","year":"1995","unstructured":"DeLorenzo RJ, Pellock JM, Towne AR, Boggs JG. Epidemiology of status epilepticus. J Clin Neurophysiol. 1995;12(4):316\u201325.","journal-title":"J Clin Neurophysiol"},{"issue":"3","key":"998_CR2","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1212\/WNL.50.3.735","volume":"50","author":"DC Hesdorffer","year":"1998","unstructured":"Hesdorffer DC, Logroscino G, Cascino G, Annegers JF, Hauser WA. Incidence of status epilepticus in Rochester, Minnesota, 1965\u20131984. Neurology. 1998;50(3):735\u201341.","journal-title":"Neurology"},{"issue":"6","key":"998_CR3","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s11910-009-0069-7","volume":"9","author":"PN Varelas","year":"2009","unstructured":"Varelas PN, Mirski MA. Status epilepticus. Curr Neurol Neurosci Rep. 2009;9(6):469\u201376.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"4","key":"998_CR4","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1001\/archneur.63.4.529","volume":"63","author":"RD Sheth","year":"2006","unstructured":"Sheth RD, Drazkowski JF, Sirven JI, Gidal BE, Hermann BP. Protracted ictal confusion in elderly patients. Arch Neurol. 2006;63(4):529\u201332.","journal-title":"Arch Neurol"},{"issue":"4","key":"998_CR5","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1111\/j.1528-1157.1986.tb03566.x","volume":"27","author":"MG Terzano","year":"1986","unstructured":"Terzano MG, Parrino L, Mazzucchi A, Moretti G. Confusional states with periodic lateralized epileptiform discharges (PLEDs): a peculiar epileptic syndrome in the elderly. Epilepsia. 1986;27(4):446\u201357.","journal-title":"Epilepsia"},{"issue":"12","key":"998_CR6","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1111\/j.1528-1157.1997.tb00073.x","volume":"38","author":"G Logroscino","year":"1997","unstructured":"Logroscino G, Hesdorffer DC, Cascino G, Annegers JF, Hauser WA. Short-term mortality after a first episode of status epilepticus. Epilepsia. 1997;38(12):1344\u20139.","journal-title":"Epilepsia"},{"issue":"Suppl 4","key":"998_CR7","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1111\/j.1528-1157.1992.tb06223.x","volume":"33","author":"RJ DeLorenzo","year":"1992","unstructured":"DeLorenzo RJ, Towne AR, Pellock JM, Ko D. Status epilepticus in children, adults, and the elderly. Epilepsia. 1992;33(Suppl 4):S15-25.","journal-title":"Epilepsia"},{"issue":"1","key":"998_CR8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1684\/j.1950-6945.2005.tb00096.x","volume":"7","author":"AC Hui","year":"2005","unstructured":"Hui AC, Lam AK, Wong A, Chow KM, Chan EL, Choi SL, et al. Generalized tonic-clonic status epilepticus in the elderly in China. Epileptic Disord. 2005;7(1):27\u201331.","journal-title":"Epileptic Disord"},{"issue":"3","key":"998_CR9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/ane.12867","volume":"137","author":"L Vilella","year":"2018","unstructured":"Vilella L, Gonz\u00e1lez Cuevas M, Quintana Luque M, Toledo M, Sueiras Gil M, Guzm\u00e1n L, et al. Prognosis of status epilepticus in elderly patients. Acta Neurol Scand. 2018;137(3):321\u20138.","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"998_CR10","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/s12028-013-9823-4","volume":"18","author":"RD Kilbride","year":"2013","unstructured":"Kilbride RD, Reynolds AS, Szaflarski JP, Hirsch LJ. Clinical outcomes following prolonged refractory status epilepticus (PRSE). Neurocrit Care. 2013;18(3):374\u201385.","journal-title":"Neurocrit Care"},{"key":"998_CR11","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1528-1157.1964.tb03337.x","volume":"5","author":"EN Arnautova","year":"1964","unstructured":"Arnautova EN, Nesmeianova TN. A proposed international classification of epileptic seizures. Epilepsia. 1964;5:297\u2013306.","journal-title":"Epilepsia"},{"issue":"7","key":"998_CR12","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1001\/jama.1993.03510070076040","volume":"270","author":"Treatment of convulsive status epilepticus","year":"1993","unstructured":"Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America\u2019s Working Group on Status Epilepticus. JAMA. 1993;270(7):854\u20139.","journal-title":"JAMA"},{"issue":"1","key":"998_CR13","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1528-1157.1999.tb02000.x","volume":"40","author":"DH Lowenstein","year":"1999","unstructured":"Lowenstein DH, Bleck T, Macdonald RL. It\u2019s time to revise the definition of status epilepticus. Epilepsia. 1999;40(1):120\u20132.","journal-title":"Epilepsia"},{"issue":"1","key":"998_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12028-012-9695-z","volume":"17","author":"G Brophy","year":"2012","unstructured":"Brophy G, Bell R, Claassen J, Alldredge B, Bleck T, Glauser T, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17(1):3\u201323.","journal-title":"Neurocrit Care"},{"issue":"10","key":"998_CR15","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1111\/epi.13121","volume":"56","author":"E Trinka","year":"2015","unstructured":"Trinka E, Cock H, Hesdorffer D, Rossetti AO, Scheffer IE, Shinnar S, et al. A definition and classification of status epilepticus \u2013 Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia. 2015;56(10):1515\u201323.","journal-title":"Epilepsia"},{"issue":"4","key":"998_CR16","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/epi.14016","volume":"59","author":"LJ Hirsch","year":"2018","unstructured":"Hirsch LJ, Gaspard N, van Baalen A, Nabbout R, Demeret S, Loddenkemper T, et al. Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions. Epilepsia. 2018;59(4):739\u201344.","journal-title":"Epilepsia"},{"key":"998_CR17","unstructured":"United Nations. Ageing 2019 [Available from: https:\/\/www.un.org\/en\/global-issues\/ageing."},{"issue":"6","key":"998_CR18","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1046\/j.1528-1157.2001.01101.x","volume":"42","author":"S Knake","year":"2001","unstructured":"Knake S, Rosenow F, Vescovi M, Oertel WH, Mueller HH, Wirbatz A, et al. Incidence of status epilepticus in adults in Germany: a prospective, population-based study. Epilepsia. 2001;42(6):714\u20138.","journal-title":"Epilepsia"},{"issue":"3\u20134","key":"998_CR19","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1159\/000111873","volume":"59","author":"V Govoni","year":"2008","unstructured":"Govoni V, Fallica E, Monetti VC, Guerzoni F, Faggioli R, Casetta I, et al. Incidence of status epilepticus in southern Europe: a population study in the health district of Ferrara, Italy. Eur Neurol. 2008;59(3\u20134):120\u20136.","journal-title":"Eur Neurol"},{"key":"998_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.seizure.2018.07.013","volume":"61","author":"H Yoshimura","year":"2018","unstructured":"Yoshimura H, Matsumoto R, Ueda H, Ariyoshi K, Ikeda A, Takahashi R, et al. Status epilepticus in the elderly: comparison with younger adults in a comprehensive community hospital. Seizure Eur J Epilepsy. 2018;61:23\u20139.","journal-title":"Seizure Eur J Epilepsy."},{"key":"998_CR21","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.eplepsyres.2016.08.016","volume":"127","author":"A Rohracher","year":"2016","unstructured":"Rohracher A, Reiter DP, Brigo F, Kalss G, Thomschewski A, Novak H, et al. Status epilepticus in the elderly\u2014a retrospective study on 120 patients. Epilepsy Res. 2016;127:317\u201323.","journal-title":"Epilepsy Res"},{"key":"998_CR22","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.seizure.2020.08.021","volume":"81","author":"M Sadeghi","year":"2020","unstructured":"Sadeghi M, Eshraghi M, Akers KG, Hadidchi S, Kakara M, Nasseri M, et al. Outcomes of status epilepticus and their predictors in the elderly\u2014a systematic review. Seizure Eur J Epilepsy. 2020;81:210\u201321.","journal-title":"Seizure Eur J Epilepsy."},{"issue":"3","key":"998_CR23","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/j.1532-5415.2004.52125_10.x","volume":"52","author":"Y Martin","year":"2004","unstructured":"Martin Y, Artaz MA, Bornand-Rousselot A. Nonconvulsive status epilepticus in the elderly. J Am Geriatr Soc. 2004;52(3):476\u20137.","journal-title":"J Am Geriatr Soc"},{"key":"998_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.yebeh.2015.04.065","volume":"49","author":"AM Kantanen","year":"2015","unstructured":"Kantanen AM, Reinikainen M, Parviainen I, Ruokonen E, Ala-Peijari M, B\u00e4cklund T, et al. Incidence and mortality of super-refractory status epilepticus in adults. Epilepsy Behav. 2015;49:131\u20134.","journal-title":"Epilepsy Behav"},{"issue":"1","key":"998_CR25","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1001\/jamaneurol.2013.578","volume":"70","author":"SE Hocker","year":"2013","unstructured":"Hocker SE, Britton JW, Mandrekar JN, Wijdicks EF, Rabinstein AA. Predictors of outcome in refractory status epilepticus. JAMA Neurol. 2013;70(1):72\u20137.","journal-title":"JAMA Neurol"},{"issue":"2","key":"998_CR26","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1001\/archneur.59.2.205","volume":"59","author":"SA Mayer","year":"2002","unstructured":"Mayer SA, Claassen J, Lokin J, Mendelsohn F, Dennis LJ, Fitzsimmons B-F. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol. 2002;59(2):205\u201310.","journal-title":"Arch Neurol"},{"key":"998_CR27","doi-asserted-by":"crossref","unstructured":"Nandal S, Castles A, Asrar Ul Haq M, van Gaal W. Takotsubo cardiomyopathy triggered by status epilepticus: case report and literature review. BMJ Case Rep. 2019;12(1).","DOI":"10.1136\/bcr-2018-225924"},{"key":"998_CR28","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.seizure.2017.08.006","volume":"51","author":"MP Malter","year":"2017","unstructured":"Malter MP, Nass RD, Kaluschke T, Fink GR, Burghaus L, Dohmen C. New onset status epilepticus in older patients: clinical characteristics and outcome. Seizure. 2017;51:114\u201320.","journal-title":"Seizure."},{"key":"998_CR29","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ebcr.2014.03.009","volume":"2","author":"M Oono","year":"2014","unstructured":"Oono M, Uno H, Umesaki A, Nagatsuka K, Kinoshita M, Naritomi H. Severe and prolonged ictal paresis in an elderly patient. Epilepsy Behav Case Rep. 2014;2:105\u20137.","journal-title":"Epilepsy Behav Case Rep."},{"issue":"8","key":"998_CR30","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1111\/j.1528-1167.2011.03084.x","volume":"52","author":"EJ Ericson","year":"2011","unstructured":"Ericson EJ, Gerard EE, Macken MP, Schuele SU. Aphasic status epilepticus: electroclinical correlation. Epilepsia. 2011;52(8):1452\u20138.","journal-title":"Epilepsia"},{"key":"998_CR31","doi-asserted-by":"publisher","first-page":"106479","DOI":"10.1016\/j.eplepsyres.2020.106479","volume":"167","author":"F Azman","year":"2020","unstructured":"Azman F, Tezer FI, Saygi S. Aphasic status epilepticus in a tertiary referral center in Turkey: clinical features, etiology, and outcome. Epilepsy Res. 2020;167:106479.","journal-title":"Epilepsy Res"},{"issue":"6","key":"998_CR32","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/j.1528-1157.1985.tb05694.x","volume":"26","author":"E Barry","year":"1985","unstructured":"Barry E, Sussman NM, Bosley TM, Harner RN. Ictal blindness and status epilepticus amauroticus. Epilepsia. 1985;26(6):577\u201384.","journal-title":"Epilepsia"},{"issue":"11","key":"998_CR33","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1001\/archneurol.2012.317","volume":"69","author":"S Shaw","year":"2012","unstructured":"Shaw S, Kim P, Millett D. Status epilepticus amauroticus revisited: ictal and peri-ictal homonymous hemianopsia. Arch Neurol. 2012;69(11):1504\u20137.","journal-title":"Arch Neurol"},{"key":"998_CR34","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.yebeh.2015.05.007","volume":"49","author":"M Leitinger","year":"2015","unstructured":"Leitinger M, Beniczky S, Rohracher A, Gardella E, Kalss G, Qerama E, et al. Salzburg consensus criteria for non-convulsive status epilepticus\u2013approach to clinical application. Epilepsy Behav. 2015;49:158\u201363.","journal-title":"Epilepsy Behav"},{"issue":"5","key":"998_CR35","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/01.nrl.0000178756.44055.f6","volume":"11","author":"RP Brenner","year":"2005","unstructured":"Brenner RP. The interpretation of the EEG in stupor and coma. Neurologist. 2005;11(5):271\u201384.","journal-title":"Neurologist"},{"issue":"5","key":"998_CR36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11940-018-0500-y","volume":"20","author":"GM Osman","year":"2018","unstructured":"Osman GM, Ara\u00fajo DF, Maciel CB. Ictal interictal continuum patterns. Curr Treat Options Neurol. 2018;20(5):15.","journal-title":"Curr Treat Options Neurol"},{"key":"998_CR37","doi-asserted-by":"publisher","first-page":"107037","DOI":"10.1016\/j.yebeh.2020.107037","volume":"106","author":"SF Zafar","year":"2020","unstructured":"Zafar SF, Subramaniam T, Osman G, Herlopian A, Struck AF. Electrographic seizures and ictal-interictal continuum (IIC) patterns in critically ill patients. Epilepsy Behav. 2020;106:107037.","journal-title":"Epilepsy Behav"},{"issue":"8","key":"998_CR38","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.clinph.2006.11.312","volume":"118","author":"J Jirsch","year":"2007","unstructured":"Jirsch J, Hirsch LJ. Nonconvulsive seizures: developing a rational approach to the diagnosis and management in the critically ill population. Clin Neurophysiol. 2007;118(8):1660\u201370.","journal-title":"Clin Neurophysiol"},{"key":"998_CR39","doi-asserted-by":"crossref","unstructured":"O'Rourke D, Chen PM, Gaspard N, Foreman B, McClain L, Karakis I, et al. Response Rates to Anticonvulsant Trials in Patients with Triphasic-Wave EEG Patterns of Uncertain Significance. Neurocrit Care. 2015.","DOI":"10.1007\/s12028-015-0151-8"},{"issue":"3","key":"998_CR40","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.neulet.2007.02.072","volume":"417","author":"T Engelhorn","year":"2007","unstructured":"Engelhorn T, Weise J, Hammen T, Bluemcke I, Hufnagel A, Doerfler A. Early diffusion-weighted MRI predicts regional neuronal damage in generalized status epilepticus in rats treated with diazepam. Neurosci Lett. 2007;417(3):275\u201380.","journal-title":"Neurosci Lett"},{"issue":"7","key":"998_CR41","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1111\/epi.16063","volume":"60","author":"M Gonz\u00e1lez-Cuevas","year":"2019","unstructured":"Gonz\u00e1lez-Cuevas M, Coscojuela P, Santamarina E, Pareto D, Quintana M, Sueiras M, et al. Usefulness of brain perfusion CT in focal-onset status epilepticus. Epilepsia. 2019;60(7):1317\u201324.","journal-title":"Epilepsia"},{"issue":"4","key":"998_CR42","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1097\/WNP.0000000000000350","volume":"34","author":"A Venkatraman","year":"2017","unstructured":"Venkatraman A, Khawaja A, Bag AK, Mirza M, Szaflarski JP, Pati SBB. Perfusion MRI can impact treatment decision in ictal-interictal continuum. J Clin Neurophysiol. 2017;34(4):e15\u20138.","journal-title":"J Clin Neurophysiol"},{"issue":"4","key":"998_CR43","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1053\/seiz.2000.0506","volume":"10","author":"F Assal","year":"2001","unstructured":"Assal F, Papazyan JP, Slosman DO, Jallon P, Goerres GW. SPECT in periodic lateralized epileptiform discharges (PLEDs): a form of partial status epilepticus? Seizure. 2001;10(4):260\u20135.","journal-title":"Seizure."},{"issue":"3","key":"998_CR44","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s12028-016-0245-y","volume":"24","author":"AF Struck","year":"2016","unstructured":"Struck AF, Westover MB, Hall LT, Deck GM, Cole AJ, Rosenthal ES. Metabolic correlates of the ictal-interictal continuum: FDG-PET during continuous EEG. Neurocrit Care. 2016;24(3):324\u201331.","journal-title":"Neurocrit Care"},{"key":"998_CR45","doi-asserted-by":"crossref","unstructured":"Young GB, Kreeft JH, McLachlan RS, Demelo J. EEG and clinical associations with mortality in comatose patients in a general intensive care unit. J Clin Neurophysiol. 1999;16.","DOI":"10.1097\/00004691-199907000-00008"},{"issue":"6","key":"998_CR46","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1111\/j.1528-1167.2008.01993.x","volume":"50","author":"FW Drislane","year":"2009","unstructured":"Drislane FW, Blum AS, Lopez MR, Gautam S, Schomer DL. Duration of refractory status epilepticus and outcome: loss of prognostic utility after several hours. Epilepsia. 2009;50(6):1566\u201371.","journal-title":"Epilepsia"},{"issue":"1","key":"998_CR47","doi-asserted-by":"publisher","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","volume":"16","author":"T Glauser","year":"2016","unstructured":"Glauser T, Shinnar S, Gloss D, Alldredge B, Arya R, Bainbridge J, et al. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the Guideline Committee of the American Epilepsy Society. Epilepsy Curr. 2016;16(1):48\u201361.","journal-title":"Epilepsy Curr."},{"issue":"12","key":"998_CR48","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1056\/NEJM199809173391202","volume":"339","author":"DM Treiman","year":"1998","unstructured":"Treiman DM, Meyers PD, Walton NY, Collins JF, Colling C, Rowan AJ, et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med. 1998;339(12):792\u20138.","journal-title":"N Engl J Med"},{"issue":"9","key":"998_CR49","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1056\/NEJMoa002141","volume":"345","author":"BK Alldredge","year":"2001","unstructured":"Alldredge BK, Gelb AM, Isaacs SM, Corry MD, Allen F, Ulrich S, et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med. 2001;345(9):631\u20137.","journal-title":"N Engl J Med"},{"issue":"7","key":"998_CR50","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1056\/NEJMoa1107494","volume":"366","author":"R Silbergleit","year":"2012","unstructured":"Silbergleit R, Durkalski V, Lowenstein D, Conwit R, Pancioli A, Palesch Y, et al. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med. 2012;366(7):591\u2013600.","journal-title":"N Engl J Med"},{"key":"998_CR51","volume-title":"4th","author":"The Treatment of Epilepsy","year":"2015","unstructured":"The Treatment of Epilepsy. 4th. edition. Oxford: Wiley Blackwell; 2015.","edition":"edition"},{"key":"998_CR52","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/s40265-015-0454-2","volume":"75","author":"E Trinka","year":"2015","unstructured":"Trinka E, H\u00f6fler J, Leitinger M, Brigo F. Pharmacotherapy for status epilepticus. Drugs. 2015;75:1499\u2013521.","journal-title":"Drugs"},{"issue":"12","key":"998_CR53","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1002\/acn3.50932","volume":"6","author":"L Kay","year":"2019","unstructured":"Kay L, Merkel N, von Blomberg A, Willems LM, Bauer S, Reif PS, et al. Intranasal midazolam as first-line inhospital treatment for status epilepticus: a pharmaco-EEG cohort study. Ann Clin Transl Neurol. 2019;6(12):2413\u201325.","journal-title":"Ann Clin Transl Neurol"},{"key":"998_CR54","doi-asserted-by":"crossref","unstructured":"Inokuchi R, Ohashi-Fukuda N, Nakamura K, Wada T, Gunshin M, Kitsuta Y, et al. Comparison of intranasal and intravenous diazepam on status epilepticus in stroke patients: a retrospective cohort study. Medicine (Baltimore). 2015;94(7):e555-e.","DOI":"10.1097\/MD.0000000000000555"},{"key":"998_CR55","unstructured":"UCB. UCB announces NAYZILAM\u00ae (midazolam) nasal spray now approved by FDA to treat intermittent, stereotypic episodes of frequent seizure activity in people living with epilepsy in the U.S.: UCB. https:\/\/www.ucb.com\/stories-media\/Press-Releases\/article\/UCB-announces-NAYZILAM-midazolam-nasal-spray-now-approved-by-FDA-to-treat-intermittent-stereotypic-episodes-of-frequent-seizure-activity-in-people-living-with-epilepsy-in-the-U-S. Accessed 8 Nov 2022."},{"key":"998_CR56","unstructured":"Neurelis. NEURELIS ANNOUNCES FDA APPROVAL FOR SEIZURE RESCUE TREATMENT VALTOCO\u00ae (DIAZEPAM NASAL SPRAY) THAT INCORPORATES THE SCIENCE OF INTRAVAIL\u00ae FOR CONSISTENT AND RELIABLE ABSORPTION 2020. https:\/\/www.neurelis.com\/neurelis-news\/neurelis-announces-fda-approval-seizure-rescue-treatment-valtocor-diazepam-nasal-spray-incorporates. Accessed 8 Nov 2022."},{"key":"998_CR57","doi-asserted-by":"crossref","unstructured":"French J, Biton V, Dave H, Detyniecki K, Gelfand MA, Gong H, et al. A randomized Phase 2b efficacy study in patients with seizure episodes with a predictable pattern using Staccato\u00ae alprazolam for rapid seizure termination. Epilepsia. 2022.","DOI":"10.1111\/epi.17441"},{"issue":"3","key":"998_CR58","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s12028-009-9295-8","volume":"11","author":"J Claassen","year":"2009","unstructured":"Claassen J, How I. Treat patients with EEG patterns on the ictal-interictal continuum in the neuro ICU. Neurocrit Care. 2009;11(3):437\u201344.","journal-title":"Neurocrit Care"},{"issue":"6","key":"998_CR59","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/NRL.0b013e31822f688c","volume":"17","author":"JL Hopp","year":"2011","unstructured":"Hopp JL, Sanchez A, Krumholz A, Hart G, Barry E. Nonconvulsive status epilepticus: value of a benzodiazepine trial for predicting outcomes. Neurologist. 2011;17(6):325\u20139.","journal-title":"Neurologist"},{"issue":"22","key":"998_CR60","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1905795","volume":"381","author":"J Kapur","year":"2019","unstructured":"Kapur J, Elm J, Chamberlain JM, Barsan W, Cloyd J, Lowenstein D, et al. Randomized trial of three anticonvulsant medications for status epilepticus. N Engl J Med. 2019;381(22):2103\u201313.","journal-title":"N Engl J Med"},{"issue":"10231","key":"998_CR61","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/S0140-6736(20)30611-5","volume":"395","author":"JM Chamberlain","year":"2020","unstructured":"Chamberlain JM, Kapur J, Shinnar S, Elm J, Holsti M, Babcock L, et al. Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial. Lancet. 2020;395(10231):1217\u201324.","journal-title":"Lancet"},{"key":"998_CR62","doi-asserted-by":"crossref","unstructured":"Nakamura K, Marushima A, Takahashi Y, Mochizuki M, Kimura A, Fukuda Y, et al. Levetiracetam versus fosphenytoin as a second-line treatment after diazepam for adult convulsive status epilepticus: a multicentre non-inferiority randomised control trial. Journal of Neurology, Neurosurgery &amp; Psychiatry. 2022:jnnp-2022-329485.","DOI":"10.1136\/jnnp-2022-329485"},{"issue":"1","key":"998_CR63","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1186\/s12883-020-02001-x","volume":"20","author":"A M\u00fcller","year":"2020","unstructured":"M\u00fcller A, Schmiedeknecht A, Mende M, Awissus C, Rosenow F, Hamer H, et al. Treatment of established status epilepticus in the elderly - a study protocol for a prospective multicenter double-blind comparative effectiveness trial (ToSEE). BMC Neurol. 2020;20(1):438.","journal-title":"BMC Neurol"},{"issue":"4","key":"998_CR64","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1212\/WNL.51.4.1034","volume":"51","author":"TJ O'Brien","year":"1998","unstructured":"O\u2019Brien TJ, Cascino GD, So EL, Hanna DR. Incidence and clinical consequence of the purple glove syndrome in patients receiving intravenous phenytoin. Neurology. 1998;51(4):1034\u20139.","journal-title":"Neurology"},{"key":"998_CR65","unstructured":"Status Epilepticus: A clinical perspective. 2nd edition ed. Cham, Switzerland: Springer; 2018."},{"issue":"11","key":"998_CR66","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1001\/jamaneurol.2021.3424","volume":"78","author":"CB Josephson","year":"2021","unstructured":"Josephson CB, Wiebe S, Delgado-Garcia G, Gonzalez-Izquierdo A, Denaxas S, Sajobi TT, et al. Association of enzyme-inducing antiseizure drug use with long-term cardiovascular disease. JAMA Neurol. 2021;78(11):1367\u201374.","journal-title":"JAMA Neurol"},{"issue":"11","key":"998_CR67","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1212\/01.WNL.0000167384.68207.3E","volume":"64","author":"AJ Rowan","year":"2005","unstructured":"Rowan AJ, Ramsay RE, Collins JF, Pryor F, Boardman KD, Uthman BM, et al. New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology. 2005;64(11):1868\u201373.","journal-title":"Neurology"},{"issue":"1","key":"998_CR68","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/epi4.12475","volume":"6","author":"JA French","year":"2021","unstructured":"French JA, Perucca E, Sander JW, Bergfeldt L, Baulac M, Auerbach DS, et al. FDA safety warning on the cardiac effects of lamotrigine: an advisory from the Ad Hoc ILAE\/AES Task Force. Epilepsia Open. 2021;6(1):45\u20138.","journal-title":"Epilepsia Open."},{"issue":"3","key":"998_CR69","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/j.1528-1167.2007.00989.x","volume":"48","author":"NA Limdi","year":"2007","unstructured":"Limdi NA, Knowlton RK, Cofield SS, Ver Hoef LW, Paige AL, Dutta S, et al. Safety of rapid intravenous loading of valproate. Epilepsia. 2007;48(3):478\u201383.","journal-title":"Epilepsia"},{"key":"998_CR70","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.seizure.2019.03.020","volume":"69","author":"J Lind","year":"2019","unstructured":"Lind J, Nordlund P. Intravenous use of valproic acid in status epilepticus is associated with high risk of hyperammonemia. Seizure. 2019;69:20\u20134.","journal-title":"Seizure."},{"key":"998_CR71","doi-asserted-by":"publisher","first-page":"107193","DOI":"10.1016\/j.yebeh.2020.107193","volume":"111","author":"SF Habhab","year":"2020","unstructured":"Habhab SF, Ulvin LB, Taub\u00f8ll E, Svalheim S, Olsen KB, Horn MA, et al. Influence of valproate-induced hyperammonemia on treatment decision in an adult status epilepticus cohort. Epilepsy Behav. 2020;111:107193.","journal-title":"Epilepsy Behav"},{"issue":"3","key":"998_CR72","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/NRL.0000000000000335","volume":"26","author":"KM Smith","year":"2021","unstructured":"Smith KM, Britton JW, Hocker SE, Toledano M. Hyperammonemia in patients with status epilepticus treated with or without valproic acid. Neurologist. 2021;26(3):80\u20132.","journal-title":"Neurologist"},{"issue":"4","key":"998_CR73","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.seizure.2010.12.015","volume":"20","author":"KJ Werhahn","year":"2011","unstructured":"Werhahn KJ, Klimpe S, Balkaya S, Trinka E, Kr\u00e4mer G. The safety and efficacy of add-on levetiracetam in elderly patients with focal epilepsy: a one-year observational study. Seizure. 2011;20(4):305\u201311.","journal-title":"Seizure."},{"issue":"6","key":"998_CR74","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1002\/ana.25249","volume":"83","author":"AM Husain","year":"2018","unstructured":"Husain AM, Lee JW, Kolls BJ, Hirsch LJ, Halford JJ, Gupta PK, et al. Randomized trial of lacosamide versus fosphenytoin for nonconvulsive seizures. Ann Neurol. 2018;83(6):1174\u201385.","journal-title":"Ann Neurol"},{"issue":"10","key":"998_CR75","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.seizure.2013.07.011","volume":"22","author":"V Belcastro","year":"2013","unstructured":"Belcastro V, Vidale S, Pierguidi L, Sironi L, Tancredi L, Striano P, et al. Intravenous lacosamide as treatment option in post-stroke non convulsive status epilepticus in the elderly: a proof-of-concept, observational study. Seizure. 2013;22(10):905\u20137.","journal-title":"Seizure."},{"issue":"6","key":"998_CR76","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1111\/epi.13716","volume":"58","author":"A Strzelczyk","year":"2017","unstructured":"Strzelczyk A, Z\u00f6llner JP, Willems LM, Jost J, Paule E, Schubert-Bast S, et al. Lacosamide in status epilepticus: systematic review of current evidence. Epilepsia. 2017;58(6):933\u201350.","journal-title":"Epilepsia"},{"issue":"10","key":"998_CR77","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1111\/j.1528-1167.2011.03212.x","volume":"52","author":"A Nizam","year":"2011","unstructured":"Nizam A, Mylavarapu K, Thomas D, Briskin K, Wu B, Saluja D, et al. Lacosamide-induced second-degree atrioventricular block in a patient with partial epilepsy. Epilepsia. 2011;52(10):e153\u20135.","journal-title":"Epilepsia"},{"issue":"5","key":"998_CR78","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.jocn.2014.11.007","volume":"22","author":"BS Kang","year":"2015","unstructured":"Kang BS, Jung KH, Shin JW, Moon JS, Byun JI, Lim JA, et al. Induction of burst suppression or coma using intravenous anesthetics in refractory status epilepticus. J Clin Neurosci. 2015;22(5):854\u20138.","journal-title":"J Clin Neurosci"},{"issue":"11","key":"998_CR79","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1001\/archneur.62.11.1698","volume":"62","author":"AO Rossetti","year":"2005","unstructured":"Rossetti AO, Logroscino G, Bromfield EB. Refractory status epilepticus: effect of treatment aggressiveness on prognosis. Arch Neurol. 2005;62(11):1698\u2013702.","journal-title":"Arch Neurol"},{"issue":"8","key":"998_CR80","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1212\/WNL.0000000000000009","volume":"82","author":"R Sutter","year":"2014","unstructured":"Sutter R, Marsch S, Fuhr P, Kaplan PW, Ruegg S. Anesthetic drugs in status epilepticus: risk or rescue? A 6-year cohort study. Neurology. 2014;82(8):656\u201364.","journal-title":"Neurology"},{"issue":"5","key":"998_CR81","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1097\/CCM.0000000000000881","volume":"43","author":"NA Marchi","year":"2015","unstructured":"Marchi NA, Novy J, Faouzi M, Stahli C, Burnand B, Rossetti AO. Status epilepticus: impact of therapeutic coma on outcome. Crit Care Med. 2015;43(5):1003\u20139.","journal-title":"Crit Care Med"},{"issue":"9","key":"998_CR82","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1097\/CCM.0b013e3182591ff1","volume":"40","author":"RG Kowalski","year":"2012","unstructured":"Kowalski RG, Ziai WC, Rees RN, Werner JKJ, Kim G, Goodwin H, et al. Third-line antiepileptic therapy and outcome in status epilepticus: The impact of vasopressor use and prolonged mechanical ventilation*. Crit Care Med. 2012;40(9):2677\u201384.","journal-title":"Crit Care Med"},{"issue":"9","key":"998_CR83","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1212\/WNL.0000000000000723","volume":"83","author":"SE Hocker","year":"2014","unstructured":"Hocker SE, Sutter R, Shorvon S. Anesthetic drugs in status epilepticus: Risk or rescue? A 6-year cohort study. Neurology. 2014;83(9):866.","journal-title":"Neurology"},{"issue":"4","key":"998_CR84","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1212\/WNL.0000000000000054","volume":"82","author":"A Fernandez","year":"2014","unstructured":"Fernandez A, Lantigua H, Lesch C, Shao B, Foreman B, Schmidt JM, et al. High-dose midazolam infusion for refractory status epilepticus. Neurology. 2014;82(4):359\u201365.","journal-title":"Neurology"},{"issue":"5","key":"998_CR85","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/epi.14706","volume":"60","author":"WG Muhlhofer","year":"2019","unstructured":"Muhlhofer WG, Layfield S, Lowenstein D, Lin CP, Johnson RD, Saini S, et al. Duration of therapeutic coma and outcome of refractory status epilepticus. Epilepsia. 2019;60(5):921\u201334.","journal-title":"Epilepsia"},{"issue":"8","key":"998_CR86","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1111\/epi.12247","volume":"54","author":"N Gaspard","year":"2013","unstructured":"Gaspard N, Foreman B, Judd LM, Brenton JN, Nathan BR, McCoy BM, et al. Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study. Epilepsia. 2013;54(8):1498\u2013503.","journal-title":"Epilepsia"},{"issue":"11","key":"998_CR87","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s40263-018-0569-6","volume":"32","author":"A Rosati","year":"2018","unstructured":"Rosati A, De Masi S, Guerrini R. Ketamine for refractory status epilepticus: a systematic review. CNS Drugs. 2018;32(11):997\u20131009.","journal-title":"CNS Drugs"},{"issue":"12","key":"998_CR88","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1111\/epi.16382","volume":"60","author":"A Fechner","year":"2019","unstructured":"Fechner A, Hubert K, Jahnke K, Knake S, Konczalla J, Menzler K, et al. Treatment of refractory and superrefractory status epilepticus with topiramate: a cohort study of 106 patients and a review of the literature. Epilepsia. 2019;60(12):2448\u201358.","journal-title":"Epilepsia"},{"issue":"3","key":"998_CR89","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/epi4.12230","volume":"3","author":"SH Mahmoud","year":"2018","unstructured":"Mahmoud SH, Rans C. Systematic review of clobazam use in patients with status epilepticus. Epilepsia Open. 2018;3(3):323\u201330.","journal-title":"Epilepsia Open."},{"key":"998_CR90","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.yebeh.2018.07.004","volume":"86","author":"F Brigo","year":"2018","unstructured":"Brigo F, Lattanzi S, Rohracher A, Russo E, Meletti S, Grillo E, et al. Perampanel in the treatment of status epilepticus: a systematic review of the literature. Epilepsy Behav. 2018;86:179\u201386.","journal-title":"Epilepsy Behav"},{"issue":"2","key":"998_CR91","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1017\/cjn.2014.121","volume":"42","author":"FA Zeiler","year":"2015","unstructured":"Zeiler FA, Zeiler KJ, Teitelbaum J, Gillman LM, West M. Modern inhalational anesthetics for refractory status epilepticus. Can J Neurol Sci. 2015;42(2):106\u201315.","journal-title":"Can J Neurol Sci"},{"issue":"11","key":"998_CR92","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1111\/epi.17055","volume":"62","author":"H Suga","year":"2021","unstructured":"Suga H, Yanagida A, Kanazawa N, Ohara H, Kitagawa T, Hayashi M, et al. Status epilepticus suspected autoimmune: neuronal surface antibodies and main clinical features. Epilepsia. 2021;62(11):2719\u201331.","journal-title":"Epilepsia"},{"issue":"18","key":"998_CR93","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1212\/WNL.0000000000001940","volume":"85","author":"N Gaspard","year":"2015","unstructured":"Gaspard N, Foreman BP, Alvarez V, Cabrera Kang C, Probasco JC, Jongeling AC, et al. New-onset refractory status epilepticus: etiology, clinical features, and outcome. Neurology. 2015;85(18):1604\u201313.","journal-title":"Neurology"},{"issue":"7","key":"998_CR94","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1111\/epi.13797","volume":"58","author":"D Dubey","year":"2017","unstructured":"Dubey D, Singh J, Britton JW, Pittock SJ, Flanagan EP, Lennon VA, et al. Predictive models in the diagnosis and treatment of autoimmune epilepsy. Epilepsia. 2017;58(7):1181\u20139.","journal-title":"Epilepsia"},{"key":"998_CR95","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jneuroim.2018.07.009","volume":"323","author":"D Dubey","year":"2018","unstructured":"Dubey D, Kothapalli N, McKeon A, Flanagan EP, Lennon VA, Klein CJ, et al. Predictors of neural-specific autoantibodies and immunotherapy response in patients with cognitive dysfunction. J Neuroimmunol. 2018;323:62\u201372.","journal-title":"J Neuroimmunol"},{"issue":"18","key":"998_CR96","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1212\/WNL.0000000000000383","volume":"82","author":"M Toledano","year":"2014","unstructured":"Toledano M, Britton JW, McKeon A, Shin C, Lennon VA, Quek AML, et al. Utility of an immunotherapy trial in evaluating patients with presumed autoimmune epilepsy. Neurology. 2014;82(18):1578\u201386.","journal-title":"Neurology"},{"key":"998_CR97","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.seizure.2016.10.012","volume":"43","author":"FA Zeiler","year":"2016","unstructured":"Zeiler FA, Matuszczak M, Teitelbaum J, Kazina CJ, Gillman LM. Plasmapheresis for refractory status epilepticus, part I: a scoping systematic review of the adult literature. Seizure Eur J Epilepsy. 2016;43:14\u201322.","journal-title":"Seizure Eur J Epilepsy."},{"key":"998_CR98","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.yebeh.2015.04.054","volume":"47","author":"AM Khawaja","year":"2015","unstructured":"Khawaja AM, DeWolfe JL, Miller DW, Szaflarski JP. New-onset refractory status epilepticus (NORSE)\u2014the potential role for immunotherapy. Epilepsy Behav. 2015;47:17\u201323.","journal-title":"Epilepsy Behav"},{"key":"998_CR99","doi-asserted-by":"crossref","unstructured":"Iizuka T, Kanazawa N, Kaneko J, Tominaga N, Nonoda Y, Hara A, et al. Cryptogenic NORSE. Its distinctive clinical features and response to immunotherapy. 2017;4(6):e396","DOI":"10.1212\/NXI.0000000000000396"},{"issue":"6","key":"998_CR100","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1002\/ana.24806","volume":"80","author":"DL Kenney-Jung","year":"2016","unstructured":"Kenney-Jung DL, Vezzani A, Kahoud RJ, LaFrance-Corey RG, Ho ML, Muskardin TW, et al. Febrile infection-related epilepsy syndrome treated with anakinra. Ann Neurol. 2016;80(6):939\u201345.","journal-title":"Ann Neurol"},{"issue":"6","key":"998_CR101","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1002\/ana.25374","volume":"84","author":"JS Jun","year":"2018","unstructured":"Jun JS, Lee ST, Kim R, Chu K, Lee SK. Tocilizumab treatment for new onset refractory status epilepticus. Ann Neurol. 2018;84(6):940\u20135.","journal-title":"Ann Neurol"},{"issue":"2","key":"998_CR102","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/WCO.0b013e32833735cf","volume":"23","author":"G Biagini","year":"2010","unstructured":"Biagini G, Panuccio G, Avoli M. Neurosteroids and epilepsy. Curr Opin Neurol. 2010;23(2):170\u20136.","journal-title":"Curr Opin Neurol"},{"key":"998_CR103","unstructured":"SAGE. September 12, 2017 Sage Therapeutics Reports Top-Line Results from Phase 3 STATUS Trial of Brexanolone in Super-Refractory Status Epilepticus 2017. https:\/\/investor.sagerx.com\/news-releases\/news-release-details\/sage-therapeutics-reports-top-line-results-phase-3-status-trial. Accessed 8 Nov 2022."},{"issue":"10","key":"998_CR104","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1212\/WNL.0000000000003690","volume":"88","author":"MC Cervenka","year":"2017","unstructured":"Cervenka MC, Hocker S, Koenig M, Bar B, Henry-Barron B, Kossoff EH, et al. Phase I\/II multicenter ketogenic diet study for adult superrefractory status epilepticus. Neurology. 2017;88(10):938\u201343.","journal-title":"Neurology"},{"key":"998_CR105","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.seizure.2015.12.015","volume":"35","author":"FA Zeiler","year":"2016","unstructured":"Zeiler FA, Matuszczak M, Teitelbaum J, Gillman LM, Kazina CJ. Electroconvulsive therapy for refractory status epilepticus: a systematic review. Seizure. 2016;35:23\u201332.","journal-title":"Seizure."},{"key":"998_CR106","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.seizure.2020.07.022","volume":"81","author":"M Sobstyl","year":"2020","unstructured":"Sobstyl M, Stapi\u0144ska-Syniec A, Rylski M. Deep brain stimulation for the treatment of refractory and super-refractory status epilepticus. Seizure Eur J Epilepsy. 2020;81:58\u201362.","journal-title":"Seizure Eur J Epilepsy."},{"issue":"3","key":"998_CR107","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/j.1365-2125.2005.02529.x","volume":"61","author":"E Perucca","year":"2006","unstructured":"Perucca E. Clinically relevant drug interactions with antiepileptic drugs. Br J Clin Pharmacol. 2006;61(3):246\u201355.","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"998_CR108","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1111\/epi.16361","volume":"60","author":"M Leitinger","year":"2019","unstructured":"Leitinger M, Trinka E, Zimmermann G, Beniczky S. Salzburg criteria for nonconvulsive status epilepticus: details matter. Epilepsia. 2019;60(11):2334\u20136.","journal-title":"Epilepsia"}],"container-title":["Drugs &amp; Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-022-00998-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-022-00998-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-022-00998-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T12:02:44Z","timestamp":1725624164000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-022-00998-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":108,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["998"],"URL":"https:\/\/doi.org\/10.1007\/s40266-022-00998-z","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"8 December 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Gamaleldin Osman: No conflicts of interest. Sara E. Hocker: Dr. Hocker consulted for MARINUS pharmaceuticals in 2021 and she is currently a site Co-PI for the RAISE study which they are funding. Dr. Hocker is an advisor for the NORSE Institute for which she receives no funding.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"The data used to support the findings of this article are available from the corresponding author upon request.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"GO: performed literature search, data analysis and initial draft of the work. SH: critically revised and edited the work. Both authors have read and approve the finally submitted form of the manuscript.","order":10,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors' contributions"}}]}}